Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

Mitochondria-Targeted Drug Development Digital Summit

Mitochondria-Targeted Drug Development Digital Summit


Date of beginning

Tuesday, 27 April 2021


3 days




Jessica Durston


This email address is being protected from spambots. You need JavaScript enabled to view it.


The Mitochondria-Targeted Drug Development Digital Summit is the only industry-led meeting focused on end-to-end mitochondria-targeting. Explore success stories from leading experts overcoming common challenges whilst exploring what's next to help you accelerate your pipeline into the clinic. With 20+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders from Larimar Therapeutics, Minovia Therapeutics, Mitokinin and many more, this comprehensive forum will completely focus on mitochondria-targeting drug development and the current challenges and opportunities in the field. Make this your 2021 must-attend meeting and network with 80+ senior CSOs, CEOs, research scientists, academics and investors committed to targeting mitochondria to tackle challenges with Mitochondrial and Age-related Diseases. Join Stealth BioTherapeutics, Cohbar, GenSight Biologics, Minovia Therapeutics and MISSION Therapeutics and many more, as they discuss how to best optimize and improve the persistence and durability of effective and scalable mitochondrial therapies this is a conversation not to miss. In this focused summit, you'll learn from the field's pioneers who'll be sharing their experience in:* Exploring the role of mitochondrial dysfunction in age-related diseases and rare genetic mitochondrial diseases* Examining early discovery and research findings* Evaluating preclinical drug development and studies* Discovering the patient perspective to aid mitochondria-targeted drug development* Assessing clinical development and showcasing current trials* Lessons learned from clinical trial design and how design can be improved to mitigate common challenges* Realizing the use of gene therapy, editing technology and innovation Incorporating insights from leading academics and pioneering biotech, uncover innovative research whilst gaining extensive technical knowledge on mitochondria-targeted therapies, this summit is your only and definitive meeting to examine the advancement of innovative therapies and drugs, focusing on the latest research in innovative targeting pathways, unique therapeutics, and new techniques to target mitochondrial dysfunction, whilst evaluating your clinical development landscape.   URLs:Tickets: Brochure: Date and Time: On Tuesday April 27, 2021 at 9:00 am (ends Thursday April 29, 2021 at 5:00 pm) Prices:Industry Pricing: Conference + 2 Workshops: USD 2697.00,Industry Pricing: Conference + 1 Workshop: USD 2348.00,Industry Pricing: Conference Only: USD 1999.00,Academic Pricing: Conference + 2 Workshops: USD 2397.00,Academic Pricing: Conference + 1 Workshop: USD 2098.00,Academic Pricing: Conference Only: USD 1799.00,Solution Providers: Conference + 2 Workshops: USD 3297.00,Solution Providers: Conference + 1 Workshop: USD 2898.00,Solution Providers: Conference Only: USD 2499.00 Speakers: Steven Engle, CohBar Inc, Magali Taiel, GenSight Biologics, Carole Ben-Maimon, Larimar Therapeutics, Mehmood Khan, Life Biosciences, Natalie Ohana Yivgi, Minovia Therapeutics, Paul Thompson, MISSION Therapeutics, John Geisler, Mitochon Pharmaceuticals, Nicholas Hertz, Mitokinin, Francesca Fieni, Pano Therapeutics, Sophie Bozec, POXEL, Matthew Klein, PTC Therapeutics, Robert Molinari, Retrotope, Reenie McCarthy, Stealth BioTherapeutics, Nathan Alder, University of Connecticut, Philip Yeske, United Mitochondrial Disease Foundation, Lan Wei-LaPierre, University of Florida, Mike Murphy, University of Cambridge, Keshav Singh, University of Alabama - Yuva Biosciences, Jake Chen, University of Alabama at Birmingham, Gyaneshwer Chaubey, BHU, Prashanth Suravajhala, Birla Institute of Scientific Research, Afshin Beheshti, KBR/NASA, Douglas Wallace, Pediatric Mitochondrial Medicine and Metabolic Disease - Center for Mitochondrial and Epigenomic Medicine - University of Pennsylvania, Daniela Bezdan, University Hospital Tuebingen - NASA GeneLab Microbiome - ISSOP, Sylvain Costes, NASA Ames Research Center, Deanne Taylor, The Children's Hospital of Philadelphia, Kapaett Satyamoorthy, Manipal School of Life Sciences, MAHE, Kira Mann, MitoAction